• Email Address: info@crispr-bte.com
  • ONUMMIX®

Course and Certification Program

Course and Certification Program

COVERnoBackground

CRISPR: REVOLUTIONISING GENOME EDITING

Few discoveries can completely transform an existing discipline, and clustered regularly interspaced short palindromic repeats (CRISPR) technology is one such breakthrough discoveries. It is not just a gene-editing tool, but a concept that allows scientists to manipulate cells like never before. With potential impact not just in the healthcare sector, the applications and the demand of the technology are set to expand exponentially.

CRISPR technology is undoubtedly one of the breakthrough discoveries in this era in genetic engineering. Originally discovered as an intrinsic component of prokaryotic defence against viruses, the CRISPR/Cas system has the prospect of becoming the leading technology in medical research, industrial biology, agriculture, and biofuel in the future. Based on the effector genes, the CRISPR/Cas system can be functionally classified into classes 1 and 2. Class 2 contains a single effector nuclease and finds the most extensive applications, and includes type II (such as CRISPR/Cas9 system), V, and VI CRISPR/Cas systems. Whereas, the class 1 CRISPR system consists of multiple subunits of effector nuclease complexes, and includes the type I, III, and IV CRISPR/Cas systems.

Owing to its precise gene-editing capability, CRISPR has accelerated research related to drug design to treat diseases such as HIV and cancer that have since long remained a challenge for conventional therapeutics. In agriculture, it has helped to improve crop yield, resistivity to diseases, pests, heat and droughts, and improving nutritional content. The technology also finds application in cattle breeding programs. It allows targeted mutations such as insertion, deletion, or regulation of gene expression to obtain desirable phenotypes, improved productivity and resistance to certain diseases. If researched extensively, CRISPR/Cas system has an unprecedented scope of DNA rewriting, and together with synthetic biology it can build complex and programmable gene circuits, and expand its current applications in therapeutics, diagnostics, and biotechnology.

The course will be launch to provide a comprehensive insight into the fundamental aspects of CRISPR technology and will aim to inform you about the emerging, cutting-edge research technologies and advanced tools used in biomedical research.

Unlocking the Potential of Genome Engineering

REGISTRATION OPEN

TO REGISTER, PLEASE CLICK HERE OR VISIT OUR DEDICATED PAGE AT https://www.cbehx.co.uk/product/crispr-revolutionising-genome-editing/

INSTRUCTORS

01

Dr. Matthias Schröder

Course Co-director

PhD in Immunology at the Division of Immunopharmacology of the University Clinic of Frankfurt am Main. Involved in basic and applied research for immunological interventions to treat cancer for 13 years. Currently involved in the development of fusion proteins to activate receptors of the TNF-superfamily (CD40, CD27 etc.) at a small German Biotech company as Head of Assay Development.
02

Dr. Christos Evangelou

Course Co-director

PhD in Cancer Biology, Division of Molecular and Clinical Cancer Sciences, University of Manchester, UK. Areas of expertise include cancer immunology, melanoma research, cancer immunotherapy, and mechanisms of immunotherapy resistance. During my PhD research, I studied the role of chronic inflammation and the cytokine IFN-gamma in adaptation and immunotherapy resistance in melanoma. By integrating high-throughput transcriptomic analyses and employing various cancer cell lines and animal models, I have developed methods to predict response to immunotherapy in melanoma patients.
03

Dr. Veronica Hughes

Course Co-director

Veronica Hughes received her PhD in medical science from the University of Florida, focusing primarily on cancer metastasis and therapeutic interventions.
04

Dr. Amrita Sarkar

Senior Writer/Editor

PhD in Chemistry with postdoctoral experience at The University of Manchester, UK. Author of 14 scientific publications in peer reviewed international journals.
05

Dr. Justine Braguy*

Medical & Scientific Illustrator/Animator

PhD in Biotechnology and Plant Science with BSc in Chemistry, Physics and Mathematics and a Master’s in Biotechnology specialized in Synthetic Biology.
*Currently finalising her PhD

THE SCOPE OF CRISPR TECHNOLOGY

The rapid advancements and extensive research have expanded the horizon for applications of CRISPR technology. In addition, it has created a future-focused industry with increasing global market demands. Therefore, a well-trained and certified professional with knowledge to design research using CRISPR as one of the biomedical tools and interpret experimental findings has unprecedented scope for etching a successful career in this domain. Simultaneously, the advanced course would provide a competitive-edge to help professionals to stay ahead of their peers. With the successful completion of the advanced certified course, be prepared to embrace the vast opportunities that lie ahead.

You don't know what CRISPR gene editing is?

Watch our short video explainer!

Students registering for our program will receive our complimentary eBook with title: The Revolution of The CRISPR-Cas9 System.

CRISPR Biotech Engineering
Proudly Supports

GET IN TOUCH

Need more information? Get in touch with our team. Our friendly and responsive customer service staff will respond to your query soon as possible.

Working Hours

Mon to Fri: 9am to 5pm

Email Address

support@crispr-bte.com

DROP US A LINE